NCT05194852

Brief Summary

A prospective randomized controlled study among 60 consecutive adhesive capsulitis to compare between the ultrasound-guided anterior hydrodilatation in rotator interval and the posterior approach.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2018

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 2, 2018

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2018

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 28, 2018

Completed
3.2 years until next milestone

First Submitted

Initial submission to the registry

December 2, 2021

Completed
2 months until next milestone

First Posted

Study publicly available on registry

January 18, 2022

Completed
Last Updated

January 18, 2022

Status Verified

January 1, 2022

Enrollment Period

6 months

First QC Date

December 2, 2021

Last Update Submit

January 14, 2022

Conditions

Outcome Measures

Primary Outcomes (2)

  • visual analoge state

    minimum value: 0 maximum value: 10 higher scores mean a worse outcome.

    3 months

  • shoulder pain and disability index

    minimum value: 0 maximum value: 100 higher scores mean a worse outcome.

    3 months

Study Arms (2)

group 1

ACTIVE COMPARATOR

Group I received ultrasound-guided hydrodilatation with corticosteroid, saline, and local anesthetic via posterior intra-articular approach

Procedure: ultrasound-guided posterior hydrodilatationDrug: corticosteroid, saline, and local anestheticOther: guided stretching and strengthening exercise program

group 2

EXPERIMENTAL

group II received the same ultrasound-guided hydrodilatation via anterior rotator interval approach

Procedure: ultrasound-guided posterior hydrodilatationOther: guided stretching and strengthening exercise program

Interventions

Group I was treated through posterior approach; The injection needle is introduced at the skin surface just lateral to the transducer and in an oblique lateral to medial direction. Group II was treated through anterior rotator interval approach. A 21-gauge needle is introduced into the rotator interval using an oblique path within the imaging plane of the transducer; from lateral to medial, the needle tip is imaged in real time throughout its passage from superficial to deep and is positioned in the biceps tendon sheath between the coracohumeral ligament above and biceps tendon below. Both groups were given the same guided stretching and strengthening exercise program

group 1group 2

corticosteroid, saline, and local anesthetic

group 1

guided stretching and strengthening exercise program

group 1group 2

Eligibility Criteria

Age35 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • patients aged 35 to 60 years,
  • patients who suffered pain and stiffness in only one shoulder, for 1 to 6 months
  • patients who had restriction of passive motion.

You may not qualify if:

  • patients with previous trauma,
  • patients with neurological
  • patients with endocrinal diseases
  • patients with shoulder tumor
  • patients with arthritis
  • people who had received intra-articular shoulder injection within the last 6 months.
  • Patients with tendon tear

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of Medicine

Tanta, Gharbia Governorate, 31527, Egypt

Location

MeSH Terms

Interventions

Adrenal Cortex HormonesSodium ChlorideAnesthetics, Local

Intervention Hierarchy (Ancestors)

HormonesHormones, Hormone Substitutes, and Hormone AntagonistsChloridesHydrochloric AcidChlorine CompoundsInorganic ChemicalsSodium CompoundsAnestheticsCentral Nervous System DepressantsPhysiological Effects of DrugsPharmacologic ActionsChemical Actions and UsesSensory System AgentsPeripheral Nervous System AgentsCentral Nervous System AgentsTherapeutic Uses

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
the participants and outcome assessor didn't know the group classification
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
associate professor

Study Record Dates

First Submitted

December 2, 2021

First Posted

January 18, 2022

Study Start

January 2, 2018

Primary Completion

June 30, 2018

Study Completion

September 28, 2018

Last Updated

January 18, 2022

Record last verified: 2022-01

Locations